CoChat

The prognostic role of Geriatric 8 in patients with cancer: a meta-analysis and systematic review

Chen, Runzhi, Yang, Dongmei, Tian, Mengxing, Xu, Huiting, Jin, Xin · 2025 · The Oncologist
Cited by 26

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Objective: Previous studies have reported conflicting results regarding the association between the Geriatric 8 (G-8) geriatric screening tool and prognosis in patients with cancer. This meta-analysis aimed to evaluate the prognostic value of the G-8 score in patients with cancer. Methods: PubMed, Cochrane Library, Embase, and Medline databases were searched to identify trials exploring the association between G-8 score and prognosis in patients with cancer. Meta-analyses of overall survival (OS) and progression-free survival (PFS) between the high and low G-8 scores were performed. The quality of the included studies was assessed using the Quality In Prognosis Studies tool. Results: A total of 42 studies involving 9053 patients with cancer were included. The prevalence of frailty, evaluated using the G-8 tool across trials, ranged from 27% to 91%. A low G-8 score was associated with poor OS (Hazard ratio [HR] 2.11; 95% CI:1.93-2.31, P <.001) and PFS (HR 1.78, 95% CI,1.55-2.05, P <.001) in patients with cancer. Overall survival were shorter in patients with low G-8 scores than in those with high G-8 scores in digestive system tumors, head and neck cancer, lung cancer, gynecologic tumors, hematologic malignancies, and prostate cancer. The predictive role of the G-8 tool was also confirmed in subgroups with G-8 cutoff values of 9-14. Patients with low G-8 scores had more advanced disease stages and higher ECOG performance status scores. Conclusions: The prevalence of frailty was high among patients with cancer according to the G-8 geriatric screening tool. Decreased G-8 scores are significantly associated with poor survival in patients with cancer. G-8 is a promising tool for frailty screening.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/oncolo/oyaf118

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 84

  1. Kiri, 2024, Cancer, metastasis, and the epigenome, Mol Cancer, 23, 154, 10.1186/s12943-024-02069-w · DOI · Paper page
  2. Han, 2024, Cancer incidence and mortality in china, 2022, J Natl Cancer Cent, 4, 47, 10.1016/j.jncc.2024.01.006 · DOI · Paper page
  3. Matsuda, 2020, Age-specific cancer incidence rate in the world, Jpn J Clin Oncol, 50, 626, 10.1093/jjco/hyaa057 · doi:10.1093/jjco/hyaa057
  4. Pawelec, 2019, Does patient age influence anti-cancer immunity, Semin Immunopathol, 41, 125, 10.1007/s00281-018-0697-6 · DOI
  5. Feliu, 2020, Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients, Clin Transl Oncol, 22, 457, 10.1007/s12094-019-02167-y · DOI
  6. Komici, 2022, Frailty in patients with lung cancer: a systematic review and meta-analysis, Chest, 162, 485, 10.1016/j.chest.2022.02.027 · DOI
  7. Clegg, 2013, Frailty in elderly people, Lancet, 381, 752, 10.1016/S0140-6736(12)62167-9 · DOI · Paper page
  8. Guida, 2024, Associations of seven measures of biological age acceleration with frailty and all-cause mortality among adult survivors of childhood cancer in the st. Jude lifetime cohort, Nat Cancer, 5, 731, 10.1038/s43018-024-00745-w · DOI
  9. Patel, 2024, Assessing frailty in gastrointestinal cancer: two diseases in one, Curr Oncol Rep, 26, 90, 10.1007/s11912-023-01483-5 · DOI
  10. Muhandiramge, 2022, Functional decline in the cancer patient: a review, Cancers (Basel), 14, 1368, 10.3390/cancers14061368 · DOI
  11. Jespersen, 2021, Frailty screening for predicting rapid functional decline, rapid progressive disease, and shorter overall survival in older patients with gastrointestinal cancer receiving palliative chemotherapy - a prospective, clinical study, J Geriatr Oncol, 12, 578, 10.1016/j.jgo.2020.10.007 · DOI
  12. Cao, 2023, Association of frailty with the incidence risk of cardiovascular disease and type 2 diabetes mellitus in long-term cancer survivors: a prospective cohort study, BMC Med, 21, 74, 10.1186/s12916-023-02774-1 · DOI
  13. Wildiers, 2014, International society of geriatric oncology consensus on geriatric assessment in older patients with cancer, J Clin Oncol, 32, 2595, 10.1200/JCO.2013.54.8347 · DOI · Paper page
  14. Parker, 2018, What is comprehensive geriatric assessment (cga)? An umbrella review, Age Ageing, 47, 149, 10.1093/ageing/afx166 · DOI · Paper page
  15. Welsh, 2014, Comprehensive geriatric assessment--a guide for the non-specialist, Int J Clin Pract, 68, 290, 10.1111/ijcp.12313 · DOI · Paper page
  16. Ellis, 2017, Comprehensive geriatric assessment for older adults admitted to hospital, Cochrane Database Syst Rev, 9, CD006211, 10.1002/14651858.CD006211.pub3 · DOI · Paper page
  17. Lundqvist, 2018, Cost-effectiveness of comprehensive geriatric assessment at an ambulatory geriatric unit based on the age-fit trial, BMC Geriatr, 18, 32, 10.1186/s12877-017-0703-1 · DOI
  18. Goede, 2023, Frailty and cancer: current perspectives on assessment and monitoring, Clin Interv Aging, 18, 505, 10.2147/CIA.S365494 · DOI · Paper page
  19. Rowbottom, 2019, Performance of the vulnerable elders survey 13 screening tool in identifying cancer treatment modification after geriatric assessment in pre-treatment patients: a retrospective analysis, J Geriatr Oncol, 10, 229, 10.1016/j.jgo.2018.10.018 · DOI
  20. Bellera, 2012, Screening older cancer patients: first evaluation of the g-8 geriatric screening tool, Ann Oncol, 23, 2166, 10.1093/annonc/mdr587 · DOI · Paper page
  21. Garcia, 2021, Screening tools for identifying older adults with cancer who may benefit from a geriatric assessment: a systematic review, JAMA Oncol, 7, 616, 10.1001/jamaoncol.2020.6736 · DOI
  22. Pearce, 2022, Frailty and treatment outcome in advanced gastro-oesophageal cancer: an exploratory analysis of the go2 trial, J Geriatr Oncol, 13, 287, 10.1016/j.jgo.2021.12.009 · DOI
  23. Morimoto, 2023, Prospective observational study evaluating the prognostic value of the g8 screening tool for extensive-stage small cell lung cancer patients who received programmed death-ligand 1 inhibitor plus platinum-etoposide chemotherapy, Drugs Aging, 40, 563, 10.1007/s40266-023-01034-4 · DOI
  24. Sekiguchi, 2022, Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy, Cancer Rep (Hoboken), 5, e1613, 10.1002/cnr2.1613 · DOI
  25. Scheepers, 2021, The g8 frailty screening tool and the decision-making process in older breast cancer patients, Eur J Cancer Care (Engl), 30, e13357, 10.1111/ecc.13357 · DOI
  26. Yajima, 2024, The significance of g8 and other geriatric assessments in urologic cancer management: a comprehensive review, Int J Urol, 31, 607, 10.1111/iju.15432 · DOI
  27. van Walree, 2019, A systematic review on the association of the g8 with geriatric assessment, prognosis and course of treatment in older patients with cancer, J Geriatr Oncol, 10, 847, 10.1016/j.jgo.2019.04.016 · DOI · Paper page
  28. Horiuchi, 2024, Predictive value of the g8 screening tool for postoperative complications in older adults undergoing cancer surgery: a systematic review and meta-analysis, J Geriatr Oncol, 15, 101656, 10.1016/j.jgo.2023.101656 · DOI
  29. Pearce, 2025, Frailty and outcomes in adults undergoing systemic anti-cancer treatment: a systematic review and meta-analysis, J Natl Cancer Inst, djaf017, 10.1093/jnci/djaf01 · doi:10.1093/jnci/djaf01
  30. Agemi, 2019, Prospective evaluation of the g8 screening tool for prognostication of survival in elderly patients with lung cancer: a single-institution study, PLoS One, 14, e0210499, 10.1371/journal.pone.0210499 · DOI
  31. Anic, 2023, The preoperative g8 geriatric screening tool independently predicts survival in older patients with endometrial cancer: results of a retrospective single-institution cohort study, J Cancer Res Clin Oncol, 149, 851, 10.1007/s00432-022-03934-1 · DOI
  32. Anic, 2022, G-8 geriatric screening tool independently predicts progression-free survival in older ovarian cancer patients irrespective of maximal surgical effort: results of a retrospective cohort study, Gerontology, 68, 1101, 10.1159/000520328 · DOI
  33. Bai, 2022, A prospective phase ii study of biweekly s-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma, J Clin Oncol, 40, 550, 10.1200/jco.2022.40.4_suppl.550 · doi:10.1200/jco.2022.40.4_suppl.550
  34. Bakas, 2023, Frailty in non-geriatric patients with head and neck cancer, Otolaryngol Head Neck Surg, 169, 1215, 10.1002/ohn.388 · DOI
  35. Banna, 2022, The geriatric g8 score is associated with survival outcomes in older patients with advanced prostate cancer in the adhere prospective study of the meet-uro network, Curr Oncol, 29, 7745, 10.3390/curroncol29100612 · DOI
  36. Beardo, 2019, Safety and outcomes of new generation hormone-therapy in elderly chemotherapy-naive metastatic castration-resistant prostate cancer patients in the real world, Arch Gerontol Geriatr, 82, 179, 10.1016/j.archger.2019.02.008 · DOI
  37. Becherini, 2023, Clinical outcome of nivolumab in older and frail patients with recurrent/metastatic head and neck squamous cell carcinoma, Journal of Geriatric Oncology, 14, 101380, 10.1016/j.jgo.2022.09.009 · DOI
  38. Bentsen, 2021, Combination of the g-8 screening tool and hand-grip strength to predict long-term overall survival in non-small cell lung cancer patients undergoing stereotactic body radiotherapy, Cancers (Basel), 13, 3363, 10.3390/cancers13133363 · DOI
  39. Couderc, 2021, Older patients treated for lung and thoracic cancers: unplanned hospitalizations and overall survival, Clin Lung Cancer, 22, e405, 10.1016/j.cllc.2020.06.004 · DOI
  40. Deluche, 2019, First validation of the g-8 geriatric screening tool in older patients with glioblastoma, J Geriatr Oncol, 10, 159, 10.1016/j.jgo.2018.07.002 · DOI
  41. Fujita, 2023, Prognostic significance of the geriatric 8 score alone and included with genetic risk group in older adults with acute myeloid leukemia, J Geriatr Oncol, 14, 101582, 10.1016/j.jgo.2023.101582 · DOI
  42. Gavriatopoulou, 2019, Vulnerability variables among octogenarians myeloma patients: a single-center analysis in 110 patients, Leuk Lymphoma, 60, 619, 10.1080/10428194 · doi:10.1080/10428194
  43. Ishii, 2021, Use of the geriatric-8 screening tool to predict prognosis and complications in older adults with head and neck cancer: a prospective, observational study, J Geriatr Oncol, 12, 1039, 10.1016/j.jgo.2021.03.008 · DOI
  44. Kadokura, 2022, Usefulness of the g8 geriatric assessment tool as a prognostic factor in gemcitabine plus nab-paclitaxel combination therapy for elderly patients with pancreatic cancer, JMA J, 5, 512, 10.31662/jmaj.2022-0086 · doi:10.31662/jmaj.2022-0086
  45. Kobayshi, 2022, A phase ii multicenter trial assessing the efficacy and safety of first-line s-1 + ramucirumab in elderly patients with advanced/recurrent gastric cancer: Kscc1701, Eur J Cancer, 166, 279, 10.1016/j.ejca.2022.02.028 · DOI
  46. Krenzlin, 2021, Frailty in glioblastoma is independent from chronological age, Front Neurol, 12, 777120, 10.3389/fneur.2021.777120 · doi:10.3389/fneur.2021.777120
  47. Kubo, 2020, Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients, Jpn J Clin Oncol, 50, 1447, 10.1093/jjco/hyaa152 · DOI
  48. Lee, 2021, Association of the geriatric 8 with treatment intensity and prognosis in older patients with diffuse large b-cell lymphoma, Br J Haematol, 194, 325, 10.1111/bjh.17554 · DOI
  49. Liao, 2023, Impaired geriatric 8 score is associated with worse survival after radical intensity modulated radiation therapy in elderly patients with nasopharyngeal carcinoma, Acta Otolaryngol, 143, 334, 10.1080/00016489.2023.2190769 · doi:10.1080/00016489.2023.2190769
  50. Liposits, 2023, Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy – the randomized nordic9-study, J Geriatr Oncol, 14, 101408, 10.1016/j.jgo.2022.11.007 · DOI
  51. Loi, 2021, Charlson comorbidity index and g8 in older old adult(≥80 years) hepatocellular carcinoma patients treated with stereotactic body radiotherapy, J Geriatr Oncol, 12, 1100, 10.1016/j.jgo.2021.01.001 · doi:10.1016/j.jgo.2021.01.001
  52. Maebayashi, 2018, Significance of stereotactic body radiotherapy in older patients with early stage non-small cell lung cancer, J Geriatr Oncol, 9, 594, 10.1016/j.jgo.2018.03.005 · doi:10.1016/j.jgo.2018.03.005
  53. Martinez-Tapia, 2017, Prognostic value of the g8 and modified-g8 screening tools for multidimensional health problems in older patients with cancer, Eur J Cancer, 83, 211, 10.1016/j.ejca.2017.06.027 · DOI
  54. Middelburg, 2021, Impaired geriatric 8 score is associated with worse survival after radiotherapy in older patients with cancer, Clin Oncol (R Coll Radiol), 33, e203, 10.1016/j.clon.2020.09.002 · DOI
  55. Momota, 2020, Geriatric 8 screening of frailty in patients with prostate cancer, Int J Urol, 27, 642, 10.1111/iju.14256 · doi:10.1111/iju.14256
  56. Nakazawa, 2021, Analysis of factors affecting progression-free survival of first-line chemotherapy in older patients with advanced gastrointestinal cancer, J Geriatr Oncol, 12, 1200, 10.1016/j.jgo.2021.05.006 · DOI
  57. Pottel, 2015, G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy, BMC Cancer, 15, 875, 10.1186/s12885-015-1800-1 · DOI
  58. Rao, 2024, Assessing frailty in older indian patients before cancer treatment: comparative analysis of three scales and their implications for overall survival, J Geriatr Oncol, 15, 101736, 10.1016/j.jgo.2024.101736 · DOI
  59. Rier, 2022, Association between geriatric assessment and post-chemotherapy functional status in older patients with cancer, Oncologist, 27, e878, 10.1093/oncolo/oyac131 · DOI
  60. Shah, 2022, G8 and ves-13 as screening tools for geriatric assessment and predictors of survival in older indian patients with cancer, J Geriatr Oncol, 13, 720, 10.1016/j.jgo.2022.02.013 · DOI
  61. Shiotsu, 2022, Pembrolizumab monotherapy for untreated pd-l1-positive non-small cell lung cancer in the elderly or those with poor performance status: a prospective observational study, Front Oncol, 12, 904644, 10.3389/fonc.2022.904644 · DOI
  62. Soubeyran, 2014, Screening for vulnerability in older cancer patients: the oncodage prospective multicenter cohort study, PLoS One, 9, e115060, 10.1371/journal.pone.0115060 · DOI · Paper page
  63. Takahashi, 2021, Phase ii study of trifluridine/tipiracil (tas-102) therapy in elderly patients with colorectal cancer (t-core1401): geriatric assessment tools and plasma drug concentrations as possible predictive biomarkers, Cancer Chemother Pharmacol, 88, 393, 10.1007/s00280-021-04277-3 · DOI
  64. Takahashi, 2017, The g8 screening tool enhances prognostic value to ecog performance status in elderly cancer patients: a retrospective, single institutional study, PLoS One, 12, e0179694, 10.1371/journal.pone.0179694 · DOI
  65. Wilk, 2022, Cardiac biomarkers and geriatric assessment in metastatic castrate-resistant prostate cancer during abiraterone acetate therapy - a cardio-oncology study, Cancer Control, 29, 10732748221140696, 10.1177/10732748221140696 · DOI
  66. Zurlo, 2022, Safety and efficacy of a first-line chemotherapy tailored by g8 score in elderly metastatic or locally advanced gastric and gastro-esophageal cancer patients: a real-world analysis, Geriatrics (Basel), 7, 107, 10.3390/geriatrics7050107 · DOI
  67. Rodriguez-Manas, 2013, Searching for an operational definition of frailty: a delphi method based consensus statement: the frailty operative definition-consensus conference project, J Gerontol A Biol Sci Med Sci, 68, 62, 10.1093/gerona/gls119 · DOI · Paper page
  68. Fried, 2004, Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care, J Gerontol A Biol Sci Med Sci, 59, 255, 10.1093/gerona/59.3.m255 · DOI · Paper page
  69. Alamgeer, 2023, Frailty and long-term survival among patients in australian intensive care units with metastatic cancer (frail-cancer study): a retrospective registry-based cohort study, Lancet Healthy Longev, 4, e675, 10.1016/S2666-7568(23)00209-X · DOI
  70. Runzer-Colmenares, 2020, Frailty and vulnerability as predictors of chemotherapy toxicity in older adults: a longitudinal study in peru, J Nutr Health Aging, 24, 966, 10.1007/s12603-020-1404-6 · DOI
  71. Narasimhulu, 2020, Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer, Gynecol Oncol, 158, 646, 10.1016/j.ygyno.2020.05.046 · DOI
  72. Guzeloz, 2024, Evaluation of treatment outcomes and tolerability in older patients with rectal cancer treated with radiotherapy accompanied by the g-8 geriatric score: Trod13-003 multicenter study, J Geriatr Oncol, 15, 101739, 10.1016/j.jgo.2024.101739 · doi:10.1016/j.jgo.2024.101739
  73. Shaw, 2022, The association of frailty with outcomes after cancer surgery: a systematic review and metaanalysis, Ann Surg Oncol, 29, 4690, 10.1245/s10434-021-11321-2 · DOI
  74. Davey, 2023, Impact of frailty on oncological outcomes in patients undergoing surgery for colorectal cancer - a systematic review and meta-analysis, Surgeon, 21, 173, 10.1016/j.surge.2022.06.001 · DOI
  75. Bullock, 2020, Relationship between markers of malnutrition and clinical outcomes in older adults with cancer: systematic review, narrative synthesis and meta-analysis, Eur J Clin Nutr, 74, 1519, 10.1038/s41430-020-0629-0 · DOI · Paper page
  76. Fu, 2024, The controlling nutritional status score as a new prognostic predictor in patients with cervical cancer receiving radiotherapy: a propensity score matching analysis, BMC Cancer, 24, 1093, 10.1186/s12885-024-12872-9 · DOI
  77. Xu, 2025, Skeletal muscle index-based cachexia index as a predictor of prognosis in patients with cancer: a meta-analysis and systematic review, Nutr Rev, 83, e852, 10.1093/nutrit/nuae094 · DOI
  78. Mori, 2019, Differences and overlap between sarcopenia and physical frailty in older community-dwelling japanese, Asia Pac J Clin Nutr, 28, 157, 10.6133/apjcn.201903_28(1).0021 · DOI
  79. Cavusoglu, 2021, Predictive ability of the g8 screening test to determine probable sarcopenia and abnormal comprehensive geriatric assessment in older patients with solid malignancies, BMC Geriatr, 21, 574, 10.1186/s12877-021-02544-9 · DOI · Paper page
  80. Xu, 2022, Prognostic value of sarcopenia in patients with diffuse large b-cell lymphoma treated with r-chop: a systematic review and meta-analysis, Front Nutr, 9, 816883, 10.3389/fnut.2022.816883 · DOI
  81. Sarfati, 2016, The impact of comorbidity on cancer and its treatment, CA Cancer J Clin, 66, 337, 10.3322/caac.21342 · DOI · Paper page
  82. Panigrahi, 2021, How comorbidities shape cancer biology and survival, Trends Cancer, 7, 488, 10.1016/j.trecan.2020.12.010 · DOI
  83. Blagden, 2003, Performance status score: do patients and their oncologists agree, Br J Cancer, 89, 1022, 10.1038/sj.bjc.6601231 · DOI · Paper page
  84. Mohile, 2009, Association of a cancer diagnosis with vulnerability and frailty in older medicare beneficiaries, J Natl Cancer Inst, 101, 1206, 10.1093/jnci/djp239 · DOI · Paper page

Metadata

Authors
Chen, R., Yang, D., Tian, M., Xu, H., & Jin, X.
Affiliations
  • Department of Medical Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei 43000,
  • Department of Clinical Nutrition, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei 43000,
Venue
The Oncologist
Published
2025-06
Volume
30
Issue
6
ISSN
  • 1083-7159
  • 1549-490X
Cited by
26
References
6
Language
en
Funders
  • National Science Foundation of Hubei Province (2024AFB1030, 2021CFB267)
  • CIFST - Abbott Foundation of Food Nutrition and Safety (202305)
  • Talent Project of Hubei Cancer Hospital (2025HBCHQHRC009)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The prognostic role of Geriatric 8 in patients with cancer: a meta-analysis and systematic review. https://app.cochat.ai/papers/10.1093/oncolo/oyaf118
The paper
Chen, R., Yang, D., Tian, M., Xu, H., & Jin, X. (2025). The prognostic role of Geriatric 8 in patients with cancer: a meta-analysis and systematic review. The Oncologist. https://doi.org/10.1093/oncolo/oyaf118

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.